Exhibit 99.3
R1 RCM Announces Leadership Succession Plan
Lee Rivas Appointed Chief Executive Officer, effective January 1, 2023; Joseph Flanagan to Continue Serving on Board
John Sparby, Chief Operating Officer, Appointed President
MURRAY, Utah, November 8, 2022 — R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that its Board of Directors has appointed Lee Rivas to succeed Joseph Flanagan as Chief Executive Officer, effective January 1, 2023, at which time Mr. Rivas will also join the Company’s Board. Mr. Flanagan will step down effective January 1, 2023, following a distinguished nearly 10-year career with R1, and will continue to serve as a member of the Company’s Board. As part of a planned succession process, Mr. Flanagan will transition to serve as Executive Advisor to the CEO.
In addition, John Sparby, who joined the Company in 2004 and currently serves as Chief Operating Officer, has been appointed to succeed Mr. Rivas as President, effective January 1, 2023.
“With the integration of Cloudmed nearing a successful completion, this is the right time for an orderly leadership transition,” said Mr. Flanagan. “Lee and I have worked closely together over the past year, and his leadership, experience, skills and passion make him the ideal person to lead our company. I am confident Lee and our team will continue to build upon R1’s long track record of delivering results to our provider partners, transforming the patient experience, supporting our global employees and driving shareholder value.”
“After almost 10 years with the Company, Joe has been transparent about his desire to transition from the CEO role in order to spend more time with his family,” said Anthony J. Speranzo, Chair of the R1 Board. “The Board and Joe have regularly discussed succession planning, and today’s announcement is the culmination of that work. On behalf of the Board and the entire R1 team, we thank Joe for his steadfast vision and leadership that have shaped R1 into a global leader and created tremendous value for our customers and shareholders.”
Mr. Speranzo continued, “Through our thoughtful and deliberate succession planning process Lee was the natural choice to succeed Joe. We are confident that Lee will build upon R1’s outstanding track record of leadership, excellence and value creation.”
Mr. Rivas said, “I am honored to lead a company with such a strong mission, team members, and track record of delivering results for providers. I look forward to building on this mission and delivering great value to our customers and other stakeholders.”
